喹诺酮类药物的体外活性 - Suppr

In vitro activities of quinolones.

作者信息

Dalhoff A

机构信息

Christian-Albrechts-Universität Kiel, Institut für Medizinische Mikrobiologie, und Virologie, Brunswiker Strasse 4, 24105 Kiel, Germany.

出版信息

Expert Opin Investig Drugs. 1999 Feb;8(2):123-37. doi: 10.1517/13543784.8.2.123.

DOI:10.1517/13543784.8.2.123

PMID:15992068

Abstract

摘要

相似文献

In vitro activities of quinolones.

Expert Opin Investig Drugs. 1999 Feb;8(2):123-37. doi: 10.1517/13543784.8.2.123.

Comparative in-vitro activities of commonly available quinolones and other antibiotics on bacterial isolates in Ibadan, Nigeria.

Afr J Med Med Sci. 2001 Mar-Jun;30(1-2):35-7.

Temafloxacin: in vitro comparison with five other antibacterial agents.

Chemotherapy. 1991;37(2):98-105. doi: 10.1159/000238840.

[Clinical evaluation of new quinolones as antituberculosis drugs].

Kekkaku. 1999 Jan;74(1):71-5.

[In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis].

Kekkaku. 1991 Jun;66(6):429-31.

Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.

J Antimicrob Chemother. 2008 Jul;62(1):98-104. doi: 10.1093/jac/dkn136. Epub 2008 Apr 4.

New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.

J Med Chem. 1992 Jan 24;35(2):361-7. doi: 10.1021/jm00080a023.

In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.

Chemotherapy. 1985;31(6):466-71. doi: 10.1159/000238375.

A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'.

J Antimicrob Chemother. 1999 May;43 Suppl B:1-11. doi: 10.1093/jac/43.suppl_2.1.

Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Eur J Clin Microbiol Infect Dis. 2002 Jan;21(1):27-34. doi: 10.1007/s100960100624.

引用本文的文献

Quinolone antibiotics.

Medchemcomm. 2019 Jun 28;10(10):1719-1739. doi: 10.1039/c9md00120d. eCollection 2019 Oct 1.

Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections.

Br J Pharmacol. 2017 Jul;174(14):2225-2236. doi: 10.1111/bph.13664. Epub 2016 Dec 7.

Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Interdiscip Perspect Infect Dis. 2012;2012:976273. doi: 10.1155/2012/976273. Epub 2012 Oct 14.

Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Infection. 2012 Jun;40(3):239-62. doi: 10.1007/s15010-012-0257-2. Epub 2012 Mar 30.

Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.

Clin Pharmacokinet. 2005;44(9):969-76. doi: 10.2165/00003088-200544090-00006.

In vitro antibacterial activity and pharmacodynamics of new quinolones.

Eur J Clin Microbiol Infect Dis. 2003 Apr;22(4):203-21. doi: 10.1007/s10096-003-0907-5. Epub 2003 Apr 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

In vitro activities of quinolones.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献